Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. 1978

G Orth, and S Jablonska, and M Favre, and O Croissant, and M Jarzabek-Chorzelska, and G Rzesa

Human papillomaviruses (HPVs) found in lesions of 11 patients suffering from epidermodysplasia verruciformis were compared to HPV type 1 (HPV-1) and HPV type 2 (HPV-2) previously characterized in plantar and common warts, respectively. Complementary RNAs (cRNAs) to HPV-1, HPV-2, and viruses obtained from two patients with epidermodysplasia verruciformis (J.D. HPV and J.K. HPV) were used in cRNA.DNA filter hybridization experiments. No sequence homology was detected between HPV-1 or HPV-2 DNAs and DNAs obtained from the 11 epidermodysplasia verruciformis HPV isolates. Furthermore, with J.D. and J.K. HPV cRNAs, epidermodysplasia verruciformis HPV DNAs fell into two groups showing little, if any, sequence homology. A lower extent of annealing was observed for the DNAs of some isolates showing a genetic heterogeneity within each of the two groups. Almost no antigenic crossreaction was detected by immunodiffusion and indirect immunofluorescence tests, either between epidermodysplasia verruciformis HPVs and HPV-1 or HPV-2 or between J.D. and J.K. HPVs. Viruses belonging to the same group have common antigenic properties, but antigenic differences were observed when two of the viruses sharing only partial DNA sequence homology were compared. Viruses related to J.D. HPV were preferentially associated with flat wart-like lesions of epidermodysplasia verruciformis and were further found in the lesions of five patients bearing multiple flat warts. Viruses related to J.K. HPV were found in morphologically distinct lesions (red spots) present in some patients with epidermodysplasia verruciformis. Thus, we propose to distinguish two other types of HPVs designated provisionally as HPV type 3 (HPV-3) and HPV type 4 (HPV-4), with J.D. and J.K. HPVs as prototypes, respectively. Malignant conversion of some epidermodysplasia verruciformis lesions is more frequently associated with HPV-4 than with HPV-3 infection.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral

Related Publications

G Orth, and S Jablonska, and M Favre, and O Croissant, and M Jarzabek-Chorzelska, and G Rzesa
November 1987, Archives of dermatology,
G Orth, and S Jablonska, and M Favre, and O Croissant, and M Jarzabek-Chorzelska, and G Rzesa
January 2008, Current topics in microbiology and immunology,
G Orth, and S Jablonska, and M Favre, and O Croissant, and M Jarzabek-Chorzelska, and G Rzesa
January 2018, Frontiers in microbiology,
G Orth, and S Jablonska, and M Favre, and O Croissant, and M Jarzabek-Chorzelska, and G Rzesa
January 1986, Ciba Foundation symposium,
G Orth, and S Jablonska, and M Favre, and O Croissant, and M Jarzabek-Chorzelska, and G Rzesa
June 2010, Bulletin de l'Academie nationale de medecine,
G Orth, and S Jablonska, and M Favre, and O Croissant, and M Jarzabek-Chorzelska, and G Rzesa
December 2014, The British journal of dermatology,
G Orth, and S Jablonska, and M Favre, and O Croissant, and M Jarzabek-Chorzelska, and G Rzesa
May 2002, Archives of dermatology,
G Orth, and S Jablonska, and M Favre, and O Croissant, and M Jarzabek-Chorzelska, and G Rzesa
December 2006, Seminars in immunology,
G Orth, and S Jablonska, and M Favre, and O Croissant, and M Jarzabek-Chorzelska, and G Rzesa
June 1982, Cancer research,
G Orth, and S Jablonska, and M Favre, and O Croissant, and M Jarzabek-Chorzelska, and G Rzesa
July 2005, The Journal of investigative dermatology,
Copied contents to your clipboard!